SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-047796
Filing Date
2024-04-16
Accepted
2024-04-16 16:25:20
Documents
10
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm242867-1_def14a.htm PRE 14A 979297
2 GRAPHIC bc_skillsmatrix-4c.jpg GRAPHIC 50391
3 GRAPHIC lg_centurytherapeutics-4clr.jpg GRAPHIC 16553
4 GRAPHIC pc_diversity-4c.jpg GRAPHIC 21044
5 GRAPHIC px_centuryproxy1pg01-bw.jpg GRAPHIC 404586
6 GRAPHIC px_centuryproxy1pg02-bw.jpg GRAPHIC 140160
7 GRAPHIC tm2212884d1-fc_evaluat4c.jpg GRAPHIC 150680
8 GRAPHIC tm2212884d1-fc_stockhol4c.jpg GRAPHIC 71566
9 GRAPHIC tm2212884d1-icon_mailpho4c.jpg GRAPHIC 58817
10 GRAPHIC tm2212884d1-icon_tick4c.jpg GRAPHIC 1688
  Complete submission text file 0001104659-24-047796.txt   2209029
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40498 | Film No.: 24848121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)